PTPI
Petros Pharmaceuticals, Inc.
$0.01
+0.00 (+0.00%)
At close · Jul 2
Market Cap
$211,861
Shares
42,372,260
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W$0.00–0.04
Avg vol 30d72K
Short int754 · 0.0% float · 1.0d
Short vol15%
Last earningsNov 15, 2022
DataDec 2020–Jul 2026
Filing10-Q · May 13
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Strong Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−55% below
−
Price vs 50-day avg
−22% below
◦
RSI (14)
30 · oversold
−
MACD trend
negative
−
52-week position
8% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $0 › 200d $0 — 200d above 50d
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
◦
Short interest
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Strong
−
Revenue growth
−12% Y/Y
+
Gross margin
76%, expanding
+
EPS growth
+98% Y/Y
−
Free cash flow
$-6.8M
+
Valuation
P/E 0 · below peers
◦
Balance sheet
net debt $2.0M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−55% below
Bearish
Price vs 50-day avg
−22% below
Bearish
RSI (14)
30 · oversold
Neutral
MACD trend
negative
Bearish
52-week position
8% · near low
Bearish
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 8%
52-wk high $0
vs 200-day avg -55%
vs 50-day avg -22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PTPI
this stock
Petros Pharmaceuticals, Inc.
|
$211,861 | -37.5% | -2.8% | 0.0 | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PTPI | -16.7% | -16.7% | -37.5% | +0.0% | -37.5% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -18.1% | -15.4% | -45.5% | +0.3% | -46.7% |